These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7006453)

  • 1. Synthesis and biological activity of [14a-3H]cryptopleurine.
    Dölz H; Söllhuber M; Trigo GG; Vázquez D; Jiménez A
    Anal Biochem; 1980 Nov; 108(2):215-9. PubMed ID: 7006453
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptopleurine--an inhibitor of translocation.
    Bucher K; Skogerson L
    Biochemistry; 1976 Nov; 15(22):4755-9. PubMed ID: 791357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of ribosomes in cryptopleurine-resistant mutants of yeast.
    Skogerson L; McLaughlin C; Wakatama E
    J Bacteriol; 1973 Nov; 116(2):818-22. PubMed ID: 4583252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of the specific interaction of [14a-3H]cryptopleurine with 80S and 40S ribosomal species from the yeast Saccharomyces cerevisiae.
    Dölz H; Vázquez D; Jiménez A
    Biochemistry; 1982 Jun; 21(13):3181-7. PubMed ID: 7049239
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics and biochemistry of cryptopleurine resistance in the yeast Saccharomyces cerevisiae.
    Sánchez L; Vásquez D; Jiménez A
    Mol Gen Genet; 1977 Nov; 156(3):319-26. PubMed ID: 340910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of bicyclic aminoalcohols. V. Duration of corneal anesthesia versus enzymatic hydrolytic rate of benzoates of 1-,2-, and 3-methyl-2-hydroxyquinolizidines.
    Zoglio MA; Soine TO; Rippie EG
    J Pharm Sci; 1971 Mar; 60(3):411-6. PubMed ID: 5572119
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of the compound proposed as the structure of lagerine and its non identity with lagerine.
    Hanaoka M; Hori N; Ogawa N; Arata Y
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1684-6. PubMed ID: 4434605
    [No Abstract]   [Full Text] [Related]  

  • 8. Photoaffinity labeling of 23 S rRNA in Escherichia coli ribosomes with poly(U)-coded ethyl 2-diazomalonyl-Phe-tRNA.
    Bispink L; Matthaei H
    FEBS Lett; 1973 Dec; 37(2):291-4. PubMed ID: 4587218
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of cryptopleurine resistance in Saccharomyces cerevisiae.
    Meade JH; Riley MI; Manney TR
    J Bacteriol; 1977 Mar; 129(3):1428-34. PubMed ID: 321427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First total synthesis of (+/-)-3-hydroxy-11-norcytisine: structure confirmation and biological characterization.
    Yohannes D; Hansen CP; Akireddy SR; Hauser TA; Kiser MN; Gurnon NJ; Day CS; Bhatti B; Caldwell WS
    Org Lett; 2008 Dec; 10(23):5353-6. PubMed ID: 19007172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptopleurine resistance: genetic locus for a 40S ribosomal component in Saccharomyces cerevisiae.
    Grant P; Sánchez L; Jiménez A
    J Bacteriol; 1974 Dec; 120(3):1308-14. PubMed ID: 4612014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of oxoquinolizidines in rabbits.
    Robertson JS; Hussain M
    Xenobiotica; 1972 Nov; 2(6):539-49. PubMed ID: 4662545
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of (3H)anisomycin and (3H)gougerotin: binding to eukaryotic ribosomes.
    Barbacid M; Vazquez D
    Methods Enzymol; 1974; 30():426-39. PubMed ID: 4604931
    [No Abstract]   [Full Text] [Related]  

  • 14. Enantioselective approach to functionalized quinolizidines: synthesis of (+)-julandine and (+)-cryptopleurine.
    Pansare SV; Dyapa R
    Org Biomol Chem; 2012 Sep; 10(33):6776-84. PubMed ID: 22821193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein synthesis in Ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine.
    Donaldson GR; Atkinson MR; Murray AW
    Biochem Biophys Res Commun; 1968 Apr; 31(1):104-9. PubMed ID: 4869942
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and antileukemic activity of 1-[(quinolizidinylalkyl)amino]4/7-R-thioxanthen-9-ones.
    Boido Canu C; Iusco G; Boido V; Sparatore F; Sparatore A
    Farmaco; 1989 Nov; 44(11):1069-82. PubMed ID: 2701964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of protein synthesis by ribosomes of the 80-S type.
    Battaner E; Vazquez D
    Biochim Biophys Acta; 1971 Dec; 254(2):316-30. PubMed ID: 4944566
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of translation in eukaryotic systems by harringtonine.
    Fresno M; Jiménez A; Vázquez D
    Eur J Biochem; 1977 Jan; 72(2):323-30. PubMed ID: 319998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation in vitro by phenanthrene alkaloids of yeast mitochondrial protein synthesis from ribosomal systems of both yeast and bacteria.
    Haslam JM; Davey PJ; Linnane AW; Atkinson MR
    Biochem Biophys Res Commun; 1968 Nov; 33(3):368-73. PubMed ID: 4881053
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebine, and tubulosine.
    Gupta RS; Siminovitch L
    Biochemistry; 1977 Jul; 16(14):3209-14. PubMed ID: 560858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.